WhiteLab Genomics
YC W22Paris, FR · Founded 2019 · 40 employees · 2 known investors
Find your way into WhiteLab Genomics
756 people in our graph share verified history with the WhiteLab Genomics team — schools, employers, funds. One of them is your warm intro.
Arhaan A.unlockedknows David Delbourgo · together at Y Combinator (overlapped)
knows the team · via The University of Chicago Booth School of Business
×8knows the team · via Y Combinator
knows the team · via The Rockefeller University
knows the team · via Advention Business Partners
WhiteLab Genomics uses AI and computational methods to analyze biological data and accelerate genomic drug discovery and development. The company serves pharmaceutical and biotech organizations seeking to reduce timelines and de-risk the development of genomic medicines.
AI & Machine LearningBiotechDeep TechHealthtechArtificial IntelligenceGene TherapyCell TherapyGenomicsFranceUnited States of AmericaEuropeAmerica / CanadaPartly Remote
Founders & leadership· Y Combinator alumni (W22)
WhiteLab Genomics was founded in 2019 by David Delbourgo and Julien Cottineau.
DD
David Delbourgoin𝕏CEO co-founderDavid Delbourgo has over two decades of healthcare industry experience across business development, marketing, and commercial operations roles, including time at GE Healthcare. He holds an MBA from Chicago Booth and a master's degree in biomedical engineering from the University of Compiègne.
JC
Julien CottineauinCo-founder · Chief Scientific Officer CSOJulien Cottineau held a senior application scientist position at Genomic Vision and completed postdoctoral research on human immune deficiencies at Rockefeller University and Necker Hospital. He earned a PhD in genetics, molecular biology, and immunology from Université Pierre & Marie Curie.
Investors · 2
Also in the syndicate · 1
Debiopharmlead
Funding
SEC filings, press & company announcements- Undisclosed amountSeries ASep 2022
Debiopharm (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
2 people who came through WhiteLab Genomics went on to found or lead other companies.
Competitors · 3
by search overlap
IDbyDNA4 shared keywordsScalable, high throughput DNA sequencing platforms.
Polaris Genomics3 shared keywordsPolaris Genomics is a Veteran-owned biotech startup mapping molecular biomarkers to develop objective, biologically-based diagnostics and novel therapeutics for mental health and neuropsychiatric conditions such as PTSD. It combines genomics and AI to advance precision mental health care.
10x Genomics 1-color3 shared keywords10x Genomics offers single cell analysis technology, including its Flex assay and Flex Apex product, which use probe-based chemistry and plate-based multiplexing to profile fresh, frozen, and FFPE samples for researchers. The tools support applications in cancer, immunology, and neuroscience, enabling gene expression and multiomic profiling of cell surface protein, intracellular protein, and CRISPR guides.
Companies competing with WhiteLab Genomics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does WhiteLab Genomics do?
- WhiteLab Genomics uses AI and computational methods to analyze biological data and accelerate genomic drug discovery and development. The company serves pharmaceutical and biotech organizations seeking to reduce timelines and de-risk the development of genomic medicines.
- Who founded WhiteLab Genomics?
- WhiteLab Genomics was founded by David Delbourgo, Julien Cottineau in 2019.
- Who are WhiteLab Genomics's investors?
- WhiteLab Genomics's investors include Y Combinator.
- Where is WhiteLab Genomics headquartered?
- WhiteLab Genomics is headquartered in Paris, FR.